PharmaTher Granted Pre-IND Meeting with the FDA for Ketamine in Parkinson’s Disease
Ryan Allway December 10th, 2020 Psychedelics PharmaTher Inc., (“PharmaTher”), a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the […]